3rd Quarter - Report

MCDERMOTT+ LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues of prescription drug pricing in Medicare and Medicaid. Rebate rule. The Inflation Reduction Act (H.R. 5376) Public Law No. 117-169. H.R. 6833 - Continuing Resolution.

LobbyistCovered position, as disclosed
RODNEY WHITLOCK 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; White House Office; Health & Human Services, Dept of (HHS)

Bills named: H.R. 6833 (117th), H.R. 5376 (117th)

Pharmacy PHA

S.1391 - Fair Accountability and Innovative Research Drug Pricing Act. Prescription drug pricing issues. Patent abuse issues. Ensuring Innovation Act and the Advancing Education on Biosimilars Act of 2021. Drug-price Transparency for Competition (DTC) Act. Prescription Drug User Fee Act. H.R. 6833 - Affordable Insulin Now Act. National Coverage Determination on Aduhelm. User Fee bills. Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act. The Inflation Reduction Act (H.R. 5376) Public Law No. 117-169. H.R. 6833 - Continuing Resolution.

LobbyistCovered position, as disclosed
RODNEY WHITLOCK 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); White House Office

Bills named: S. 1391 (117th), H.R. 6833 (117th), H.R. 5376 (117th)

Copyright/Patent/Trademark CPT

The Stalling Act. The Affordable Prescriptions for Patients through promoting Competition Act of 2021. S.4430 - Interagency Patent Coordination and Improvement Act of 2022.

LobbyistCovered position, as disclosed
RODNEY WHITLOCK 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 4430 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.